Delivery Order SPE2DB22D1202-SPE2DB25FUNP4

Award Date 1/2/25
Potential Completion Date 1/24/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a delivery order contract valued at $3,518.40 for the supply of NUBEQA 300 MG TABLET 120S. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,691.72 firm fixed-price delivery order is for the supply of NUBEQA 300 MG tablets, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,641.98 firm fixed-price delivery order is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $21,110.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564287851 NUBEQA 300 MG TABLET 120S, a prescription pharmaceutical product. The award is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to $999,999,999.00 through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,691.72 firm fixed-price delivery order is for the supply of 120 count tablets of the pharmaceutical product NUBEQA 300 MG. The contract has a completion date of December 11, 2024 and was awarded on November 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,683.97 firm fixed-price delivery order is for the supply of NUBEQA 300 MG tablets, a prescription medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award, valued at $4,683.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of the drug NUBEQA 300 MG, and has a completion date of November 12, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award, valued at $4,845.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 120 tablets of the medication NUBEQA 300 MG. The contract has an ultimate completion date of January 22, 2025 and is a Firm Fixed Price arrangement. This award is not associated with any set-aside requirements. AmerisourceBergen Drug Corp holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,691.72 firm fixed-price delivery order is for the supply of NUBEQA 300 mg tablets. The contract has an ultimate completion date of December 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $4,683.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a completion date of September 26, 2024. The contract is a Delivery Order under a Firm Fixed Price (FFP) arrangement. There is no set-aside designation indicated for this award. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUNP4
    Delivery Order

This federal contract award, valued at $15,283.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, is for the supply of the pharmaceutical product NUBEQA 300 MG TABLET 120S. This contract supports the DLA's mission of providing medical products and supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, as the prime contractor, will be responsible for delivering the required pharmaceutical product to the specified location in Conshohocken, Pennsylvania by the ultimate completion date of January 24, 2025.

Generated 4/3/25, 11:10 AM